The U.S. Food and Drug Administration (FDA) announced today that one jalapeno pepper sample is a positive genetic match with the Salmonella Saintpaul strain causing the current Salmonella outbreak.
The positive sample was obtained during an FDA inspection at a produce distribution center in McAllen, Texas. The pepper was grown on a farm in Mexico, however, that does not mean that the pepper was contaminated in Mexico.
The produce distribution center, Agricola Zaragoza, is working with FDA to voluntarily recall jalapeno peppers the company distributed since June 30, 2008.
Since a recall will not immediately remove all potentially contaminated peppers from the food supply, FDA is also asking consumers to avoid eating raw jalapeno peppers or foods made from raw jalapeno peppers until further notice in order to prevent additional cases of illness. This recommendation does not include cooked or pickled jalapeno peppers.
The FDA is continuing to advise that people in high-risk populations, such as elderly persons, infants and people with impaired immune systems, avoid eating raw serrano peppers or food made from raw serrano peppers until further notice..
Discovery of the positive jalapeno pepper sample was the result of several weeks of investigation by FDA scientists and field staff – including examining traceback data from the locations where there were clusters of foodborne illness, scrutinizing distribution records and collecting environmental samples from water, soil, work surfaces and packing boxes throughout the entire chain of production and distribution.
The FDA is continuing to investigate the other parts of the distribution chain to determine if there is any evidence that the contamination occurred on the farm in which the pepper was grown or at some other point in the supply chain before the distribution center in McAllen, Texas.
According to the CDC, 1,251 persons with Salmonella Saintpaul with the same genetic fingerprint have been identified in 43 states, the District of Columbia and Canada since April 2008. For more details, click here.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.